95 percent, 94 percent. and 67%: what really shows the effectiveness of COVID-19 vaccines

“I do not want to compare things that do not need to be compared, but only to be vaccinated with a vaccine that has the opportunity to be vaccinated,” he said at the COVID-19 Infection and Vaccination conference: What can we do better? organized by the Kaunas Clinics of the Lithuanian University of Health Sciences (LSMU)? from the speaking clinical doctor, clinical pharmacologist Simona Stankevičiūtė.

She was supported by Dr. Alergist, Clinical Allergist and Immunologist from the Kaunas Clinic, who also spoke at the conference. Ieva Bajoriūnienė. “There are different types of vaccines. The question often arises which vaccine is better, it triggers a more stable immune response that would require a single dose, of course, which one is safer?

There is no one-size-fits-all answer. They are all, we might say, quite different. But in terms of effectiveness, they are all effective enough to protect against COVID-19 disease and its severe form.

According to the researchers, experience from clinical trials shows that the evidence for safety is also good. The most common are mild to moderate side effects, more often local, less common systemic. There are few serious side effects or we cannot tell the frequency of serious side effects from the number studied. There are certain conditions of transport, storage and use. “